Equity Profile
Post-Earnings Recap
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.06 | N/A | +33.33% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.06 | N/A | +33.33% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a sense of optimism about current demand. They emphasized their commitment to innovation and customer satisfaction.
Management highlighted strong demand for their vascular products.
They expressed confidence in maintaining their market position despite economic challenges.
Lemaitre Vascular's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. The stock rose by nearly 3% following the announcement, reflecting investor confidence in the company's performance. However, the lack of revenue data and guidance leaves some uncertainty about future growth prospects.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
HAEMONETICS CORP MAS